These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30622023)

  • 21. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
    Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
    J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
    [No Abstract]   [Full Text] [Related]  

  • 22. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.
    Mony L; Kew JN; Gunthorpe MJ; Paoletti P
    Br J Pharmacol; 2009 Aug; 157(8):1301-17. PubMed ID: 19594762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-channel properties of N-methyl-D-aspartate receptors containing chimaeric GluN2A/GluN2D subunits.
    O'Leary T; Wyllie DJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1347-54. PubMed ID: 19909274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
    Khatri A; Burger PB; Swanger SA; Hansen KB; Zimmerman S; Karakas E; Liotta DC; Furukawa H; Snyder JP; Traynelis SF
    Mol Pharmacol; 2014 Nov; 86(5):548-60. PubMed ID: 25205677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
    Wilding TJ; Lopez MN; Huettner JE
    J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel allosteric modulator binding sites in NMDA receptors: A molecular modeling study.
    Kane LT; Costa BM
    J Mol Graph Model; 2015 Sep; 61():204-13. PubMed ID: 26280688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential Inhibition of Tonically over Phasically Activated NMDA Receptors by Pregnane Derivatives.
    Vyklicky V; Smejkalova T; Krausova B; Balik A; Korinek M; Borovska J; Horak M; Chvojkova M; Kleteckova L; Vales K; Cerny J; Nekardova M; Chodounska H; Kudova E; Vyklicky L
    J Neurosci; 2016 Feb; 36(7):2161-75. PubMed ID: 26888927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of GluN2A-containing N-methyl-D-aspartate receptors by 2-naphthoic acid.
    Yu H; Popescu GK
    Mol Pharmacol; 2013 Oct; 84(4):541-50. PubMed ID: 23873856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel class of negative allosteric modulators of NMDA receptor function.
    Katzman BM; Perszyk RE; Yuan H; Tahirovic YA; Sotimehin AE; Traynelis SF; Liotta DC
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5583-8. PubMed ID: 26525866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potential.
    Geoffroy C; Paoletti P; Mony L
    J Physiol; 2022 Jan; 600(2):233-259. PubMed ID: 34339523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting
    Carles A; Freyssin A; Perin-Dureau F; Rubinstenn G; Maurice T
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612544
    [No Abstract]   [Full Text] [Related]  

  • 32. Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.
    Yi F; Mou TC; Dorsett KN; Volkmann RA; Menniti FS; Sprang SR; Hansen KB
    Neuron; 2016 Sep; 91(6):1316-1329. PubMed ID: 27618671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-D-aspartate receptors.
    Irvine MW; Costa BM; Volianskis A; Fang G; Ceolin L; Collingridge GL; Monaghan DT; Jane DE
    Neurochem Int; 2012 Sep; 61(4):593-600. PubMed ID: 22265875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zelquistinel acts at an extracellular binding domain to modulate intracellular calcium inactivation of N-methyl-d-aspartate receptors.
    Zhang XL; Li YX; Berglund N; Burgdorf JS; Donello JE; Moskal JR; Stanton PK
    Neuropharmacology; 2024 Nov; 259():110100. PubMed ID: 39117105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Dihydropyrrolo[1,2-
    Epplin MP; Mohan A; Harris LD; Zhu Z; Strong KL; Bacsa J; Le P; Menaldino DS; Traynelis SF; Liotta DC
    J Med Chem; 2020 Jul; 63(14):7569-7600. PubMed ID: 32538088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity.
    Sakurai F; Yukawa T; Kina A; Murakami M; Takami K; Morimoto S; Seto M; Kamata M; Yamashita T; Nakashima K; Narita N; Bettini E; Ugolini A; Corsi M; Hasui T
    Bioorg Med Chem; 2022 Feb; 56():116576. PubMed ID: 35051811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allosteric Interactions between NMDA Receptor Subunits Shape the Developmental Shift in Channel Properties.
    Sun W; Hansen KB; Jahr CE
    Neuron; 2017 Apr; 94(1):58-64.e3. PubMed ID: 28384476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of M4 Transmembrane Segments in NMDA Receptor Function: A Negative Allosteric Modulatory Site at the GluN1 M4 is Determining the Efficiency of Neurosteroid Modulation.
    Langer K; Müller-Längle A; Wempe J; Laube B
    Front Pharmacol; 2021; 12():769046. PubMed ID: 34658899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allosteric antagonist action at triheteromeric NMDA receptors.
    Gibb AJ
    Neuropharmacology; 2022 Jan; 202():108861. PubMed ID: 34736958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a Dihydroquinoline-Pyrazoline GluN2C/2D-Selective Negative Allosteric Modulator of the
    D'Erasmo MP; Akins NS; Ma P; Jing Y; Swanger SA; Sharma SK; Bartsch PW; Menaldino DS; Arcoria PJ; Bui TT; Pons-Bennaceur A; Le P; Allen JP; Ullman EZ; Nocilla KA; Zhang J; Perszyk RE; Kim S; Acker TM; Taz A; Burton SL; Coe K; Fritzemeier RG; Burnashev N; Yuan H; Liotta DC; Traynelis SF
    ACS Chem Neurosci; 2023 Sep; 14(17):3059-3076. PubMed ID: 37566734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.